Placeholder image

Volume 11 - Issue# 3 - Year 2021


Welcome to SOLACI/CACI 2021 Scientific Program
Alfredo E Rodríguez

We are glad to inform you that we finally have a starting date for the SOLACI/CACI 2021 Congress. To this date, and after two years of work, over 3112 participants, will have the opportunity of assessing the results that will be presented for the first time. On behalf of all those who have been a part of the Scientific Committee and have collaborated writing the Scientific Program, ...


Welcome to XXVI Congress of the Latin American Society ...
Aníbal Damonte

It is with great pleasure that we welcome you to the 26th Annual Meeting of the Latin American Society of Interventional Cardiology and the 31th Annual Meeting of the Argentinian College of Interventional Cardiologists, SOLACI CACI ’21. On this occasion, and due to the epidemiological context of the COVID 19 pandemic, that affects the world, and especially our region, limiting the ...


Welcome to SOLACI/CACI 2021 Congress
Diego Grinfeld

My dear Latin American colleagues, friends, and partners, It is an honor, a great privilege to welcome you all from Argentina to the most important scientific meeting in Interventional Cardiology in Latin America, and one of the most prestigious ones across the world: the SOLACI-CACI Congress. We would have loved to welcome you all in-person in our home country in Buenos Aires, Arge...

Artículo de Revisión

Colchicine and residual inflammatory risk; two old play...
Pablo Corral y cols.

Over a century, the process of atherosclerosis has been associated with the phenomenon of subendothelial accumulation of cholesterol, and the corresponding formation of atherosclerotic plaque [1]. Not much time later, in the mid-1800, Virchow described the inflammatory phenomenon associated with this process suggesting inflammation as the causal factor in atherosclerosis [2]. As decades went ...

Artículo Original

Incidence rate of long-term infective endocarditis afte...
A Matías Rodríguez-Granillo y cols.

Currently, the indications for transcatheter aortic valve implantation (TAVI) have gone from the management of inoperable or high-surgical risk patients with symptomatic, severe aortic stenosis to the management of younger low-surgical risk patients with fewer comorbidities with similar results compared surgical aortic valve replacement (SAVR). Infective endocarditis (IE) is a rare disease th...

Caso Clínico

Valve-in-valve transcatheter aortic valve implantation ...
José María Milanesi y cols.

The association between aortic valve disease and subaortic membrane (SAoM) is rare. The guidelines on the management of this entity have not been established in the current clinical practice guidelines yet. However, surgery is the treatment of choice in most cases. This is the case of a patient with severe bioprosthetic aortic valve dysfunction associated with SAoM and solved through valve-in...

Resúmenes de trabajos

Abstracts for SOLACI/CACI 2020/2021 Congress
Several authors

The coronary guidewire trick for increasing trasradial access success in little old ladies.Heber Tejeriba Segovia, José Escalante, Yesica Lescano, Osvaldo Pompe.Policlínico Bancario 9 de Julio. Sanatorio Colegiales. Argentina.Aims: Transradial access (TRA) success is higher than 95%. In some populations is lower: women, elderly and small patients. In little old ladies (LOL) TRA ...

Placeholder image

Placeholder image

Placeholder image

Placeholder image

Placeholder image

Placeholder image


Reciba la revista gratis en su correo

Suscribase gratis a nuestra revista y recibala en su correo antes de su publicacion impresa.


Colegio Argentino de Cardioangiólogos Intervencionistas
Viamonte 2146 6° (C1056ABH) Ciudad Autónoma de Buenos Aires | Argentina | tel./fax +54 11 4952-2117 / 4953-7310 |e-mail |

Colegio Argentino de Cardioangiólogos Intervencionistas | ISSN 2250-7531 | ISSN digital 2313-9307

La plataforma Meducatium es un proyecto editorial de Publicaciones Latinoamericanas S.R.L.
Piedras 1333 2° C (C1240ABC) Ciudad Autónoma de Buenos Aires | Argentina | tel./fax +54 11 5217-0292 | e-mail |

Meducatium versión ST